Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Steroids in head injury

D F Kelly1

  • 1Division of Neurosurgery, University of California at Los Angeles School of Medicine, USA.

New Horizons (Baltimore, Md.)
|August 1, 1995
PubMed
Summary
This summary is machine-generated.

High-dose corticosteroids do not improve outcomes for traumatic brain injury patients. Potential complications like hyperglycemia and gastrointestinal bleeding outweigh any benefits, making routine use inadvisable.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pulmonary Granulomas Associated with PAS-Positive Bodies in Brachycephalic Dogs.

Veterinary pathology·2018
Same author

Investigating the effect of AS03 adjuvant on the plasma cell repertoire following pH1N1 influenza vaccination.

Scientific reports·2016
Same author

Proposed closure of Inverness disease surveillance centre.

The Veterinary record·2015
Same author

Impact of new surveillance plans.

The Veterinary record·2015
Same author

Endoscopic endonasal approach for the treatment of schwannomas of the pterygopalatine fossa: case report and review of the literature.

Neuro-Chirurgie·2014
Same author

Future of disease surveillance.

The Veterinary record·2013
Same journal

Palliative care in the intensive care unit.

New horizons (Baltimore, Md.)·2001
Same journal

An international perspective on the treatment of pediatric shock: the Brazilian experience.

New horizons (Baltimore, Md.)·1998
Same journal

Nutrition and shock in pediatric patients.

New horizons (Baltimore, Md.)·1998
Same journal

Recent advances in pediatric cardiopulmonary resuscitation and advanced life support.

New horizons (Baltimore, Md.)·1998
Same journal

Potential protective role of the heat shock response in sepsis.

New horizons (Baltimore, Md.)·1998
Same journal

Molecular biology of septic shock.

New horizons (Baltimore, Md.)·1998
See all related articles

Area of Science:

  • Neuroscience
  • Critical Care Medicine
  • Pharmacology

Background:

  • Traumatic brain injury (TBI) is a significant cause of mortality and morbidity.
  • Intracranial hypertension is a common and dangerous complication of TBI.
  • Corticosteroids have been explored for their potential anti-inflammatory effects in TBI.

Purpose of the Study:

  • To evaluate the efficacy of high-dose corticosteroid therapy in managing intracranial hypertension and improving neurologic outcomes in TBI patients.
  • To assess the safety profile of corticosteroid administration in this patient population.

Main Methods:

  • Review of prospective, randomized clinical trials examining high-dose corticosteroid therapy in traumatic brain injury.
  • Analysis of data on intracranial pressure management and long-term neurologic outcomes.

Related Experiment Videos

  • Evaluation of adverse events associated with corticosteroid use, including hyperglycemia and gastrointestinal hemorrhage.

    • Main Results:

    • High-dose corticosteroid therapy failed to ameliorate intracranial hypertension in TBI patients.
    • No significant improvement in long-term neurologic outcomes was observed with corticosteroid treatment.
    • While relatively low, risks of hyperglycemia and gastrointestinal hemorrhage were noted.

    Conclusions:

    • High-dose corticosteroid therapy is ineffective for treating intracranial hypertension in TBI.
    • The potential for adverse events makes routine glucocorticoid use unwarranted in head-injured patients.
    • Evidence from multiple trials supports the discontinuation of corticosteroids for TBI management.